<DOC>
	<DOCNO>NCT02638636</DOCNO>
	<brief_summary>The purpose study examine internet-based exposure therapy effective reduce Fibromyalgia symptom impact amongst patient Fibromyalgia .</brief_summary>
	<brief_title>Internet-based Exposure-based Therapy Fibromyalgia : A Randomized Controlled Trial .</brief_title>
	<detailed_description>Trial Objectives : Primary objective investigate whether Internet-based exposure therapy effectively reduce degree Fibromyalgia symptom impact . Secondary objective 1 ) investigate treatment 's ability reduce degree ) quality life b ) function c ) insomnia fatigue ) pain-related fear negative thought e ) depression anxiety , cost-effectiveness treatment ; 2 ) study variable could moderate/mediate treatment outcome , ) degree covert avoidance , b ) degree reactivity inner sensation Trial Design : Randomized control trial waitlist control , also receive treatment first group finish . Duration : Ten week Primary Endpoint : Change Fibromyalgia symptom impact baseline Week 10 . Long term follow-up also investigate ( potential change post-treatment 6- 12 month treatment completion ) Efficacy Parameters : Fibromyalgia Impact Questionnaire ( FIQ ) Description Trial Subjects : Patients &gt; 18 year old , Fibromyalgia diagnosis , reside Sweden . Number Subjects : 140 Sample size estimation : Sample size base estimate effect size ( measure Cohen 's ) 0.5 , base power 0.8 room 10 % dropout rate . Recruitment : Self-referral . Advertising make national newspaper , social medium patient organisation ' website . Safety parameter : Participants opportunity report adverse event treatment posttreatment follow-up measurement . Data collection : Data collect electronically via treatment platform . Plan miss data : Last-observation carry forward ( LOCF ) . Main statistical analysis : Hierarchical linear mixed modelling .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Fibromyalgia diagnosis Swedish resident Internet connection , treatment Willing refrain concurrent psychological treatment study Agreement keep psychotrophic medication constant study Severe depression ( ≥30 point Montgomery Åsberg Depression Rating Scale Self Rated ( MADRSS ) risk suicide ( ≥4 point suicide item MADRSS ) Ongoing alcohol substance abuse Psychosis Other severe illness require immediate treatment and/or consider participant primary concern FM , bodily condition make treatment unfeasible ( late pregnancy ; &gt; 29 week gestation Illiteracy poor skill Swedish language Insufficient computer language skill manage textbased treatment . Other concurrent psychological treatment Recent change psychotrophic medication ( &lt; 6 week prior randomization )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Cognitive behavior therapy</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>Exposure therapy</keyword>
	<keyword>Fibromyalgia</keyword>
</DOC>